Mattea Heck

发表

The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti–Cancer Treatment

D. Cameron, J. Thomson, P. Hall, 2023, The oncologist.

Scottish COVID CAncer iMmunity Prevalence (SCCAMP) - a longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic

E. Furrie, K. Purshouse, H. McCaughan, 2022, medRxiv.